PML School
Forum to help write and understand PML
Q&A from Lesson 10: Turnover III - Nonlinear DispositionStarted by bwendt@certara.com , 06 Mar 2017 PML, Turnover, Saturated |
|
|
||
Q&A from Lesson 11: Analysis and comparison of a link, turnover and receptor binding modelStarted by bwendt@certara.com , 17 Mar 2017 PML, Link, Turnover, Receptor |
|
|
||
Q&A from Lesson 12: Sigmoidal Response modelsStarted by Christopher Mehl , 03 Apr 2017 |
|
|
||
Q&A from Lesson 13: Modeling Tumor Growth/KillStarted by bwendt@certara.com , 18 Apr 2017 PML, Tumor Growth |
|
|
||
Q&A from Lesson 14: Modeling Enzyme Inhibition by Means of TurnoverStarted by Christopher Mehl , 03 May 2017 Enzyme Inhibition, Turnover |
|
|
||
Q&A from Lesson 15: Effect Compartment III - IV InfusionStarted by bwendt@certara.com , 21 Jun 2017 PML, Link, Effect compartment and 1 more... |
|
|
||
Q&A from Lesson 16: Warfarin IV bolus Turnover modelsStarted by Christopher Mehl , 12 Jun 2017 |
|
|
||
Q&A from Lesson 19: Dose-response-time analysisStarted by bwendt@certara.com , 28 Jul 2017 Turnover, Bacterial Growth and 1 more... |
|
|
||
Q&A from Lesson 1: Nonlinear ClearanceStarted by bwendt@certara.com , 27 Oct 2016 pml |
|
|
||
Q&A from Lesson 20: Transduction ModelingStarted by bwendt@certara.com , 11 Aug 2017 PMl, Transit, Feedback |
|
|
||
Q&A from Lesson 2: Metabolite KineticsStarted by bwendt@certara.com , 27 Oct 2016 PML, parent, metabolite |
|
|
||
Q&A from Lesson 3: Two-Compartment Repeated DosingStarted by bwendt@certara.com , 10 Nov 2016 PML, PKPD, multiple dose |
|
|
||
Q&A from lesson 4: Multiple Absorption via Graphical Model BuilderStarted by bwendt@certara.com , 19 Dec 2016 PML, Graphical Model, Absorption |
|
|
||
Q&A from Lesson 5: Simultaneous Fitting of Plasma and Urine DataStarted by bwendt@certara.com , 19 Dec 2016 PML, Urine |
|
|
||
Q&A from Lesson 6: Target-Mediated Drug Disposition (TMDD)Started by Christopher Mehl , 19 Dec 2016 PML, TMDD |
|
|
||
Q&A from Lesson 7: Enterohepatic RecirculationStarted by bwendt@certara.com , 24 Jan 2017 pml, ehc |
|
|
||
Q&A from Lesson 8: One-compartment 1st and 0-order inputStarted by bwendt@certara.com , 05 Feb 2017 pml, zero-order |
|
|
||
Q&A from Lesson 9: Allometric ScalingStarted by bwendt@certara.com , 01 Mar 2017 PML, Allometry |
|
|
||
Q&A from second session NONMEM-2-NLME: 2-compartment oral with categorical covariateStarted by bwendt@certara.com , 13 Mar 2018 NONMEM, NLME, Categorical and 1 more... |
|
|
||
Q&A from second session NONMEM-2-NLME: 2Comp Plasma UrineStarted by bwendt@certara.com , 26 Feb 2018 NONMEM, NLME, Plasma, Urine and 2 more... |
|
|
||
Q&A from session about mPBPK ModelStarted by bwendt@certara.com , 15 Dec 2017 PML, mPBPK |
|
|
||
Q&A from session about nonlinear elimination model and bootstrapStarted by bwendt@certara.com , 24 May 2018 nonlinear elimination, bootstrap |
|
|
||
Q&A from session about NONMEM-NLME Indirect Response with IV BolusStarted by bwendt@certara.com , 03 Jul 2018 NONMEM, PML, Indirect |
|
|
||
Q&A from session about PKPD 1comp-Emax with baseline, shape and effectStarted by bwendt@certara.com , 13 Jul 2018 NONMEM, NLME, PKPD, Emax, Effect |
|
|
||
Q&A from session about TMDD QE ModelStarted by bwendt@certara.com , 18 Dec 2017 PML, TMDD, QE |
|
|
||
Running simulation in command line modeStarted by vetpharma , 08 Jun 2022 |
|
|
||
Target-mediated Drug Disposition (TMDD) Modeling Using the Quasi-equilibrium AssumptionStarted by bwendt@certara.com , 30 Nov 2017 PML, TMDD, QE |
|
|
||
The gamma Delay statementStarted by Davidq8 , 27 Feb 2022 gamma Delay |
|
|
||
Third peak on PK profilesStarted by Xiuqing Gao , 31 Oct 2019 |
|
|
||
Transit compartment codesStarted by Davidq8 , 13 Jan 2022 |
|
|